Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rhythm Expands Phase 2 Clinical Trials of Setmelanotide for the Treatment of Bardet-Biedl Syndrome O

americanpharmaceuticalreviewMay 18, 2017

Tag: Rhythm , obesity

PharmaSources Customer Service